Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
May 03, 2022 01:05 ET
|
Curium
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) -- Curium announced today it has successfully enrolled and dosed patients in the ECLIPSE Trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized...
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
April 19, 2022 01:00 ET
|
Curium
ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market. Curium will now...
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
April 05, 2022 01:05 ET
|
Curium
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug...
Terrestrial Energy and ANSTO Sign Agreement for Used IMSR Fuel Management
February 02, 2022 08:29 ET
|
Terrestrial Energy Inc.
SYDNEY, Australia and OAKVILLE, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ANSTO, Australia’s knowledge centre for nuclear science and technology, and Terrestrial Energy have agreed to explore ANSTO...
Global Radiopharmaceuticals Market Analysis Report 2021: Market to Reach $8.9 Billion by 2026 - COVID-19 Presents Generational Opportunity
January 27, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
January 25, 2022 01:29 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company...
Global Nuclear Medicine Markets, Analysis, Forecast & Opportunities, 2016-2020 & 2021-2026
December 31, 2021 09:33 ET
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market, By Type, By Diagnostic Nuclear Medicine, By Therapeutic Nuclear Medicine, By Application, By Diagnostic Applications,...
Outlook on the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Market to 2026 - Featuring Accuray, Bayer Pharma and Nordion Among Others
October 26, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report...
Global Nuclear Medicine/Radiopharmaceuticals Market (2021 to 2026) - Use of Radiopharmaceuticals in Neurological Applications Presents Opportunities
September 21, 2021 06:23 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha...
Michael Didocha Joins Telix as Chief Financial Officer, Americas
August 31, 2021 07:12 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Michael Didocha has joined the...